Search Results for 'elixir medical corporation'
-
Cardiovascular
Elixir Medical Unveils DynamX Stent Featuring Adaptive Segments That Uncage the Stented Artery
Company reveals new category of ‘bioadaptive drug eluting stents.’Business Wire 11.14.17
-
Cardiovascular
Elixir Medical Shares Five-Year Data for DESolve Drug-Eluting Bioresorbable Coronary Scaffold
Data indicate DESolve shows a low overall MACE rate with no additional clinically-indicated target lesion revascularizations.Business Wire 05.31.17
-
Cardiovascular
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA Bioresorbable Scaffold
Product is designed to maintain the large artery in the thigh open and restore blood flow to the leg.Business Wire 11.01.16
